Kiora Pharmaceuticals Ownership | Who Owns Kiora Pharmaceuticals?
Kiora Pharmaceuticals Ownership Summary
Kiora Pharmaceuticals is owned by 1.12% institutional investors, and 98.88% retail investors. Fidelity Extended Market Index is the top mutual fund, with 0.46% of its assets in Kiora Pharmaceuticals shares.
KPRX Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Kiora Pharmaceuticals | 1.12% | - | 98.88% |
Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2022 | 10 | -16.67% | 834,020 | 0.43% | 1 | 90.14% | 5 | -28.57% | 2 | - |
Mar 31, 2022 | 12 | 20.00% | 830,430 | 3.22% | 1 | 95.64% | 7 | -30.00% | 2 | - |
Dec 31, 2021 | 10 | - | 804,501 | - | 1 | - | 10 | - | - | - |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Fidelity Extended Market Index | 13.74K | 0.46% | -1.07K |
Vanguard Institutional Extnd Mkt Idx Tr | 2.73K | 0.09% | - |
NT Ext Equity Mkt Idx Fd - L | 2.66K | 0.09% | -1.00 |
Northern Trust Extended Eq Market Idx | 2.66K | 0.09% | -1.00 |
Bridgeway Omni Small-Cap Value | 2.00K | 0.07% | 2.00K |
BlackRock Extended Equity Market K | 1.35K | 0.05% | -1.00 |
Fidelity Series Total Market Index | 686.00 | 0.02% | 470.00 |
NT Ext Eq Mkt Indx Fd DC Lending Tier 5 | 411.00 | 0.01% | 1.00 |
Extended Equity Market Fund M | 171.00 | 0.01% | - |
Spartan Extended Market Index Pool E | 60.00 | 0.00% | 60.00 |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Sep 11, 2024 | Stengone Carmine N. | - | Buy | $4.60K |
Sep 10, 2024 | Shapiro Aron | - | Buy | $10.80K |
Aug 19, 2024 | Walters-Hoffert Lisa | - | Buy | $4.83K |
Aug 19, 2024 | TYLE PRAVEEN | - | Buy | $19.80K |
Aug 14, 2024 | Tosca Melissa | CFO | Buy | $6.42K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q3 | 5 | - |
2024 Q2 | 4 | - |
2023 Q3 | - | - |
2023 Q1 | - | - |
2022 Q4 | - | - |
KPRX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools